The Chemours's Revenue in the fiscal year 2025 $ 6,078.00 millions
The Chemours's Revenue in the fiscal year 2024 $ 5,782.00 millions
The Chemours's Revenue in the fiscal year 2023 $ 6,027.00 millions
The Chemours's Revenue in the fiscal year 2022 $ 6,794.00 millions
The Chemours's Revenue in the fiscal year 2021 $ 6,345.00 millions
CC Revenue second quarter 2026 Y/Y Growth Comment
The Chemours Company reported decrease in Revenue in the second quarter 2026 by -1.49% to $ 1,591.00 millions, from the same quarter in 2025. The decrease in the second quarter 2026 The Chemours Company's Revenue compares unfavorably to the Company's average Revenue growth of 3.79%.
Looking into second quarter 2026 results within Chemical Manufacturing industry 34 other companies have achieved higher Revenue growth. While The Chemours Company' s Revenue decline of -1.49% ranks overall at the positon no. 2489 in the second quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
The Chemours's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
177.28 %
3.09 %
-67.24 %
(Sep 30 2025)
CC's II. Quarter Q/Q Revenue Comment
The Chemours Company achieved in the II. Quarter 2026 above company average sequential Revenue jump of 15.21%, to $ 1,591.00 millions, from $1,381.00 millions in the first quarter.
Within Chemical Manufacturing industry 13 other companies have achieved higher Revenue quarter on quarter growth. While The Chemours's Revenue growth quarter on quarter, overall rank is 632.
The Chemours Company achieved in the II. Quarter 2026 above company average sequential Revenue jump of 15.21%, to $ 1,591.00 millions, from $1,381.00 millions in the first quarter.
Within Chemical Manufacturing industry 13 other companies have achieved higher Revenue quarter on quarter growth. While The Chemours's Revenue growth quarter on quarter, overall rank is 632.
The Chemours's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 8,917.00
$ 8,941.00
$ 8,928.00
$ 8,854.00
$ 5,877.00
Y / Y Revenue Growth (TTM)
51.73 %
54.16 %
54.41 %
53.98 %
2.46 %
Year on Year Revenue Growth Overall
Ranking
# 2350
# 1941
# 1647
# 1559
# 1989
Seqeuential Revenue Change (TTM)
-0.27 %
0.15 %
0.84 %
50.66 %
1.33 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2489
# 1869
# 1410
# 1317
# 1591
Cumulative Revenue growth Comment
Assuming the The Chemours's fiscal year would have ended in Jun 30 2026, The Chemours would have reprted above average annual Revenue growth of 51.73% year on year, of $ 8,917 millions. This marks a slow-down of the companys growth trends and from the 54.16% increase in Mar 31 2026.
In the Basic Materials sector 131 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1941 to 2350.
Assuming the The Chemours's fiscal year would have ended in Jun 30 2026, The Chemours would have reprted above average annual Revenue growth of 51.73% year on year, of $ 8,917 millions. This marks a slow-down of the companys growth trends and from the 54.16% increase in Mar 31 2026.
In the Basic Materials sector 131 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1941 to 2350.
About The Chemours Revenue Growth Rates (CC), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.